PubMed Health⌕ Search

Biomedical subjects

H Stöhr

Publications and source records attributed to H Stöhr.

60 records · Page 4Linked to original sources
PubMed1975

[The phenolics of fruits. VI. The phenolics of currants, gooseberries and blueberries. Changes in phenolic acids and catechins during development of black currants (author's transl)].

Black, red, and white currants, gooseberries and cultivated blueberries contained only small amounts of catechins (total up to 30 mg per kg). Hydroxycinnamic acid derivatives, especially of caffeic and p-coumaric acid, occured mostly in higher concentrations. Furthermore, 4-hydroxygenzoic acid, protocatechuic acid and gallic acid were found after hydrolysis in currants and only protocatechuic acid in gooseberries in different levels. Salicyclic and gentisic acid were found in traces up to 2 mg per kg, occassionally vanillic acid, syringic acid or isoferulic acid. The concentrations of the examined phenolic acids in black currants related to the whole fruit (mg per fruit) increased, and related to fresh weight (mg per 1000 g) decreased during the growth of the fruits with the exception of protocatechuic acid, which appeared mostly in a last stage of the fruit.

Benzopyrans↗
PubMedDate not supplied

Refined mapping of the gene encoding the p127 kDa UV-damaged DNA-binding protein (DDB1) within 11q12-q13.1 and its exclusion in Best's vitelliform macular dystrophy.

Best's vitelliform macular dystrophy (Best's disease) is an autosomal dominant disorder of unknown causes and is typically characterised by an accumulation of lipofuscin-like material in the subretinal space of the macula. The disease gene has been localised to chromosome 11q12-13.1 within a 1.4 Mbp interval flanked by markers at D11S1765 and uteroglobin (UGB). Here we report the refined mapping of the gene encoding the p127 kDa subunit (DDB1) of a UV damage-specific DNA binding protein within the D11S1765-UGB region. Northern blot analysis demonstrates an abundant expression of the DDB1 transcript in the retina suggesting a functional role for DDB1 in this tissue. These considerations together with the chromosomal localisation have led us to evaluate the possible involvement of DDB1 in the pathogenesis of Best's disease.

Base Sequence↗
PubMedDate not supplied

[Functional electrostimulation of paraplegic patients--1 year's practical application. Results in patients and experiences].

In October 1982 two patients suffering from paraplegia ware, world wide for the first time, implanted two 8-channel-stimulation-devices at the II. Surgical Clinics Vienna. Four electrodes were fixed to the nervus femoralis and the nervus gluteus inferior with the help of microsurgical techniques. The aim of the operation is to enable the paralysed patient to "stand up himself" and to "cover a short distance on crutches". They must learn to manipulate the implanted "more-channel-device" with their fingers, and to coordinate this with the supporting function and the balance function of their arms. The wheel-chair shall not and cannot be substituted with this method: Not without, but with wheel-chair and functional electrostimulation. A comprising training-programme for building up muscles, balance control and gait training was necessary. After 4 months muscle-force and endurance had increased 200%. The patients could stand up stimulatedly without help between parallel bars. At the rehabilitation center Bad Häring the first steps were done in March 1983 (= 5. month after operation). The greatest success was when a patient could get stimulatedly out of her car and do the through-swing-gait over a distance of 60 meters. After one year the muscle force was quadrupled, the endurance was increased 20-30 times, depending on the type of gait. Both patients are able to walk in the 4-P-gait or swing-through-gait on crutches over short distances without help from others. Riding a bicycle stimulatedly on even ground was demonstrated.

Adult↗
PubMedDate not supplied

Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency.

Mnestic disturbances in alcoholics may be related to cholinergic deficiency as well as to central nervous system inactivation. After instillation of tropicamide, cholinergic receptors are blocked and pupillary dilatation occurs. It is assumed that the more severe the cognitive deterioration, the wider the pupillary dilatation. Pupillary oscillations reflect central activation. Changes of pupillary diameter after topical instillation of tropicamide and pupillary oscillations were measured in 44 alcohol-dependent patients aged 40-55 years, diagnosed according to the DSM-III-R as severe alcoholics (>7 symptoms), having been abstinent for at least 3 weeks (objectively tested with carbohydrate-deficient transferrin), compared with 18 healthy controls. The pupillary diameter of the left eye was measured eight times within 103 min, as were pupillary oscillations. Using Fourier analysis, the amplitudes of oscillations were measured in five frequency bands and the sum of the frequency bands was calculated. In addition, central activation was measured during a calculation test at 3 and 103 min. The pupillary dilatation of 22% in alcoholics compared to 14% of normal controls after tropicamide raises the question of a cholinergic deficit in alcohol dependence. With regard to basic activation, measured by Fourier analysis of pupillary oscillations, alcoholics demonstrated significantly lower power (sum of the frequency bands) than controls at baseline and at 3, 20, and 40 min (P < 0.01) as well as at 60, 80, 100, and 103 min (P < 0.05). After a cognitive task, a difference between alcoholics and healthy controls was found at 3 min. Alcoholics showed lower basic activation and decreased cognitive activation. By means of cross-validation, a differentiation between alcohol-dependent patients (n = 44 and n = 42 respectively) and normal controls (n = 18) was possible.

Adult↗
PubMedDate not supplied

[Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].

A double-blind, placebo-controlled pharmaco-EEG and psychometric study was carried out to investigate the encephalotropic and psychotropic properties of a metabolically active hemoderivate (Actovegin) in 10 elderly subjects with a mean age of 65 years, and to form hypotheses about its therapeutic efficacy. They received randomized and in weekly intervals single oral doses of 6 dragées (drg.) Actovegin, 9 drg. Actovegin as well as placebo. Computer-assisted spectral analysis of the EEG demonstrated an increase of alpha- and beta-activities, an acceleration of the alpha-centroid as well as of the centroid of the total activity after Actovegin as compared with placebo, while slow activities tended to decrease--specifically in the 4th and 6th hour. These neurophysiological alterations indicate an improvement in vigilance of the elderly subjects, which was reflected in the psychometric tests. The latter demonstrated in the multivariate analysis a significant superiority of Actovegin over placebo. Actovegin induced--especially after 6 drg.--an increase in critical flicker frequency, prolongation of the after-effect as evaluated by means of the Archimedean spiral, shortening of reaction time as well as cognitive improvement in the Pauli-Test. In the autonomic nervous system, the widening of the pupillary diameter and the increase in skin conductance suggested also an activation at the ANS level. Our controlled investigations demonstrate that Actovegin--even after oral administration--may produce neurophysiological and clinical effects.

Aged↗